2025 HFSA Annual Scientific Meeting OnDemand
Program Overview
The 2025 HFSA Annual Scientific Meeting OnDemand includes recordings of the scientific sessions presented during the HFSA Annual Scientific Meeting 2025. Learners can view these recorded presentations to enhance their knowledge and stay up to date on the latest advances in heart failure care, treatment, research, and more.

Learning Highlights

  • Access 50+ expert-led sessions covering every major advancement in heart failure care—from AI and digital health to novel devices, LVAD management, and cardio-oncology.
  • Earn CME, NCPD, CPE, and ABIM MOC credits across multidisciplinary topics designed for the entire heart failure care team.
  • Catch the plenaries you missed, including 30 Years of HFSA and Late-Breaking Clinical Research sessions featuring cutting-edge therapies and future directions.
  • Learn from real-world cases and rapid-fire updates packed with practical insights for immediate application in clinical practice.
  • Watch anytime, anywhere—revisit sessions, pause, and learn at your own pace with on-demand streaming and downloadable materials.
Target Audience
This educational activity, developed from HFSA’s Annual Scientific Meeting, is intended for physicians, nurses, nurse practitioners, pharmacists, scientists, and other health care professionals who specialize in or have an interest in heart failure.
Accreditation Statement



In support of improving patient care, The Heart Failure Society of America is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


Physicians
HFSA designates this activity for a maximum of 43.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this activity, which includes participation in the evaluation component and post-test with 75% passing score, enables the participant to earn up to 9.00 MOC contact hours in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program.

Nurses

This educational activity is approved for Nursing Continuing Professional Development (NCPD) units by the Heart Failure Society of America. This activity is approved for a maximum of 43.25 contact hours (which includes 15.25 hours of nursing pharmacology).

Pharmacists
The Heart Failure Society of America is an accredited provider of continuing pharmacy education (CPE). This activity is accredited for up to 25.50 contact hours of knowledge-based CPE. ACPE Universal Activity Numbers (UAN): JA4008267-0000-25-010- H01-P (on-demand/home study).

Learners should claim only the credit commensurate with the extent of their participation in the activity.



Physician Associates/Assistants
The Heart Failure Society of America has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 43.25 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
 
Genetic Counselors
The National Society of Genetic Counselors (NSGC) has authorized the Heart Failure Society of America to offer up to 4.75 NSGC Category 1 contact hours. The American Board of Genetic Counseling will accept these CEUs for purposes of genetic counselor recertification. NSGC User IDs are required, and certificates will be delivered through the NSCG CEU Portal. Learners should claim only the credit commensurate with the extent of their participation in the activity.

This activity is approved for 43.25 contact hours (4.325 CEUs) of general continuing education for health care professionals.

Learners should claim only the credit commensurate with the extent of this participation in the activity.

The HFSA reports ABIM MOC, Continuing Pharmacy Education (CPE), National Society of Genetic Counselors (NSGC CEU) contact hours directly to their respective governing bodies.
Learning Objectives
Following this activity, participants will be better able to:

  1. Describe the epidemiology of HF and strategies for the prevention of HF.
  2. Discuss the current scientific understanding of HF from the perspectives of cardiovascular physiology, neurohormones, molecular biology, and genetics.
  3. Describe the findings of basic science research and recent clinical trials and describe their implications for current and future HF therapy.   Implement guideline-based therapy for HF, including pharmacologic agents and non-pharmacologic options such as diet, exercise, and implantable devices.
  4. Manage comorbidities including hypertension, diabetes, depression, sleep apnea, and obesity.
  5. Demonstrate awareness of psychosocial, economic, regulatory, and ethical issues in the treatment of patients with HF.
  6. Explain the patient, provider, and system-related factors that contribute to racial and ethnic health disparities.
  7. Implement strategies for effective management of the patient with HF, incorporating the family, encouraging self-care, and employing the team approach.
  8. Outline strategies for transitioning patients from inpatient to outpatient care and for reducing hospital readmissions.
  9. Engage in performance measurement and site-based research.
Specific learning objectives for each of the scientific sessions and are listed in the session description in the on-demand product.
2025 Annual Scientific Meeting Program Committee

2025 Chair
Amanda Vest, MBBS, MPH, FHFSA 2025 Co-Chair
Justin Vader, MD, FHFSA 2025 Co-Chair
Susan Bionat, DNP, FHFSA 2025 Co-Chair
Kathleen Faulkenberg, PharmD, BCPS, FHFSA

Program Committee
Jennifer Thibodeau, MD, MSCS, FHFSA
Dan Judge, MD, FHFSA
Quin Denfeld, PhD, RN, FHFSA
Douglas Jennings, PharmD

Competencies Addressed
The 2025 scientific program contains content that addresses the following ABMS core competencies.
  • Patient care
  • Medical knowledge
  • Interpersonal and communications skills
  • Professionalism
  • Systems-based practice
  • Sessions also address the following ABIM-specified competency areas in advanced heart failure and transplant cardiology:
    • Epidemiology and risk factors
    • Pathophysiology of heart failure
    • Hemodynamics and hemodynamic monitoring
    • Heart failure and normal ejection fraction
    • Heart failure with renal dysfunction / cardiorenal syndrome
    • Diagnostic tests and procedures
    • Acute decompensation of chronic heart failure
    • Subset of patients with heart failure, including women, the elderly, and different racial or ethnic groups
    • Heart failure comorbidities
    • Heart failure and pregnancy
    • Cardiomyopathies
    • Pharmacotherapy
    • Implantable devices
    • Heart transplant
    • Mechanical circulator support
    • End-of-Life Issues
Summary
Availability:
On-Demand
Expires on Oct 27, 2026
Cost:
Member: $499.00
Non-Member: $599.00
Credit Offered:
Credits Offered: 43.25 CME; 9 MOC; NCPD 43.25 (inlcuding 15.25 nursing pharmacology); 25.50 CPE; 43.25 AAPA; 4.75 NSGC; 43.25 CEUs
Contains:
Powered by Oasis.